STOCK TITAN

AlphaTime flags going-concern doubt, $4.49M deficit

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

AlphaTime Acquisition Corp. reported a $159,875 net loss for the three months ended March 31, 2026, versus $117,969 net income a year earlier. Formation and operating costs were $202,143, and Trust Account income was $42,268. Its proposed HCYC business combination remains uncompleted; the $11.5 million PIPE is expected to close substantially concurrently with, and is conditioned on, the combination.

At March 31, 2026, cash outside the Trust Account was $1,233, the Trust Account held $4,841,963, and the working capital deficit was $4,491,174. Management said the deficit and potential liquidation raise substantial doubt about going concern, and its plans do not alleviate that doubt. Disclosure controls were ineffective due to a material weakness in review of related-party transactions.

Shareholders authorized up to eight one-month extensions through December 4, 2026; each takes effect only after five days’ advance notice and a $15,000 deposit. $565,144 in extension payments was undeposited at March 31, leaving uncertainty about whether some extensions took effect and the business-combination deadline. Nasdaq delisted the securities; they are not listed on any national securities exchange.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

3 major · 5 points

How the balance works

Positive

  • None.

Negative

  • Major pointManagement said its plans did not alleviate going-concern doubt at March 31, 2026.
  • Major pointRelated-party review weakness left disclosure controls ineffective at March 31, 2026.
  • Major pointNasdaq delisting left ATMC securities unlisted on any national securities exchange.
  • Moderate pointUndeposited extension payments totaled $565,144 at March 31, 2026. 1.7% of market cap
  • Minor pointQuarterly earnings shifted from $117,969 income to a $159,875 loss.

Filing Explained

Neither the conditional PIPE issuance nor 382,091 elected redemptions has yet changed ownership because the combination remains unclosed.

The approved HCYC combination remains uncompleted, and the filing specifies that its conditional PIPE would issue 1,150,000 ordinary shares at $10 per share, plus warrants to buy up to 2,300,000 more shares at $10 per share.

If the PIPE closes and the warrants are exercised, those additional shares would increase the share count and reduce existing holders’ percentage ownership. Separately, holders of 382,091 shares elected to redeem in connection with the combination, but those redemptions have not become effective and take effect only at closing.

Net loss $159,875 Three months ended March 31, 2026
Net income $117,969 Three months ended March 31, 2025
Cash outside Trust Account $1,233 As of March 31, 2026
Trust Account $4,841,963 As of March 31, 2026
Working capital deficit $4,491,174 As of March 31, 2026
Undeposited extension payments $565,144 As of March 31, 2026
PIPE financing $11.5 million Expected to close substantially concurrently with, and conditioned on, the Business Combination
working capital deficit financial
"a working capital deficit of $4,491,174"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
temporary equity financial
"presented as temporary equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
two-class method financial
"allocated between the redeemable ordinary shares and the non-redeemable ordinary shares"
deferred underwriting commission financial
"deferred underwriting commission of $2,415,000"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the status of ATMC’s HCYC merger and PIPE financing?

AlphaTime entered a merger agreement with HCYC on January 5, 2024, and shareholders approved it on December 5, 2025; the Business Combination had not closed as of the report. The $11.5 million PIPE financing is expected to close substantially concurrently with, and is conditioned on, the combination.

What extensions did ATMC shareholders authorize?

Shareholders authorized up to eight one-month extensions through December 4, 2026. Each monthly extension takes effect only after five days’ advance notice to the trustee and a $15,000 Trust Account deposit. Extension payments totaling $565,144 had not been deposited as of March 31, 2026.

Why were ATMC securities delisted from Nasdaq?

Nasdaq cited the company exceeding the maximum three-year period permitted for a special purpose acquisition company to complete an initial business combination following its IPO. Trading was suspended January 7, 2026, and the securities had not traded on Nasdaq since December 9, 2025.

How much did ATMC pay shareholders who elected to redeem in April 2026?

The company paid $79,701.15 in April 2026 to holders of 6,135 ordinary shares who exercised redemption rights in connection with the March 27, 2026 meeting. The payment was approximately $12.99 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q1 --12-31 0001889106 0001889106 2026-01-01 2026-03-31 0001889106 ATMC:UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember 2026-01-01 2026-03-31 0001889106 ATMC:OrdinarySharesParValue0.0001PerShareMember 2026-01-01 2026-03-31 0001889106 ATMC:WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember 2026-01-01 2026-03-31 0001889106 ATMC:RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember 2026-01-01 2026-03-31 0001889106 2026-11-12 0001889106 2026-03-31 0001889106 2025-12-31 0001889106 us-gaap:RelatedPartyMember 2026-03-31 0001889106 us-gaap:RelatedPartyMember 2025-12-31 0001889106 2025-01-01 2025-03-31 0001889106 ATMC:RedeemableOrdinarySharesMember 2026-01-01 2026-03-31 0001889106 ATMC:RedeemableOrdinarySharesMember 2025-01-01 2025-03-31 0001889106 ATMC:NonRedeemableOrdinarySharesMember 2026-01-01 2026-03-31 0001889106 ATMC:NonRedeemableOrdinarySharesMember 2025-01-01 2025-03-31 0001889106 us-gaap:CommonStockMember 2025-12-31 0001889106 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001889106 us-gaap:RetainedEarningsMember 2025-12-31 0001889106 us-gaap:CommonStockMember 2024-12-31 0001889106 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001889106 us-gaap:RetainedEarningsMember 2024-12-31 0001889106 2024-12-31 0001889106 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001889106 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001889106 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001889106 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001889106 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001889106 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001889106 us-gaap:CommonStockMember 2026-03-31 0001889106 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001889106 us-gaap:RetainedEarningsMember 2026-03-31 0001889106 us-gaap:CommonStockMember 2025-03-31 0001889106 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001889106 us-gaap:RetainedEarningsMember 2025-03-31 0001889106 2025-03-31 0001889106 us-gaap:IPOMember 2023-01-02 2023-01-04 0001889106 us-gaap:IPOMember 2023-01-04 0001889106 us-gaap:OverAllotmentOptionMember 2023-01-05 2023-01-06 0001889106 us-gaap:OverAllotmentOptionMember 2023-01-06 0001889106 us-gaap:PrivatePlacementMember ATMC:SponsorMember 2023-01-02 2023-01-04 0001889106 us-gaap:PrivatePlacementMember ATMC:SponsorMember 2023-01-04 0001889106 us-gaap:PrivatePlacementMember ATMC:SponsorMember 2023-01-09 2023-01-09 0001889106 us-gaap:IPOMember 2023-01-09 2023-01-09 0001889106 us-gaap:IPOMember 2023-01-09 0001889106 2023-01-09 2023-01-09 0001889106 ATMC:BCMeetingMember 2025-12-05 2025-12-05 0001889106 ATMC:SecuritiesPurchaseAgreementsMember 2025-09-14 2025-09-14 0001889106 ATMC:SecuritiesPurchaseAgreementsMember 2025-09-14 0001889106 2023-09-27 2023-09-27 0001889106 ATMC:PromissoryNoteMember 2023-09-26 0001889106 2023-12-28 0001889106 2023-12-28 2023-12-28 0001889106 2024-12-20 0001889106 2024-12-20 2024-12-20 0001889106 2025-10-01 0001889106 2025-10-01 2025-10-01 0001889106 2025-12-16 0001889106 2025-12-16 2025-12-16 0001889106 2026-03-27 0001889106 2026-03-27 2026-03-27 0001889106 2024-01-03 0001889106 ATMC:PromissoryNoteMember ATMC:SponsorMember 2023-12-28 0001889106 ATMC:PromissoryNoteMember 2026-03-31 0001889106 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2025-12-31 0001889106 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2026-01-01 2026-03-31 0001889106 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2026-03-31 0001889106 us-gaap:IPOMember 2026-01-01 2026-03-31 0001889106 us-gaap:OverAllotmentOptionMember 2026-01-01 2026-03-31 0001889106 us-gaap:OverAllotmentOptionMember 2026-03-31 0001889106 us-gaap:IPOMember 2026-03-31 0001889106 us-gaap:PrivatePlacementMember ATMC:SponsorMember 2026-01-01 2026-03-31 0001889106 us-gaap:PrivatePlacementMember ATMC:SponsorMember 2026-03-31 0001889106 us-gaap:PrivatePlacementMember 2026-01-01 2026-03-31 0001889106 us-gaap:PrivatePlacementMember ATMC:SponsorMember 2023-01-05 2023-01-06 0001889106 us-gaap:CommonClassBMember 2021-09-27 2021-09-28 0001889106 ATMC:SponsorMember 2022-01-08 0001889106 srt:MaximumMember us-gaap:CommonStockMember 2022-01-07 2022-01-08 0001889106 ATMC:PromissoryNoteMember ATMC:SponsorMember 2026-03-31 0001889106 ATMC:PromissoryNoteMember ATMC:SponsorMember 2025-12-31 0001889106 ATMC:SponsorMember srt:MaximumMember 2026-01-01 2026-03-31 0001889106 ATMC:UnitPurchaseOptionMember 2026-01-01 2026-03-31 0001889106 ATMC:UnitPurchaseOptionMember 2026-03-31 0001889106 ATMC:HCYCHoldingCompanyMember 2026-03-31 0001889106 ATMC:HCYCHoldingCompanyMember 2025-12-31 0001889106 us-gaap:CommonClassAMember 2026-03-31 0001889106 us-gaap:WarrantMember 2026-03-31 0001889106 us-gaap:SubsequentEventMember 2026-04-01 2026-04-30 0001889106 us-gaap:SubsequentEventMember 2026-04-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

Or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number 001-41584

 

ALPHATIME ACQUISITION CORP

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A (00-0000000)

(State or Other Jurisdiction

of Incorporation)

 

(I.R.S. Employer

Identification No.)

     

500 5th Avenue, Suite 938

New York, NY 10110

  N/A
(Address of principal executive offices)   (zip code)

 

(347) 627-0058

(Issuer’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbols   Name of Each Exchange on Which Registered
Units, each consisting of one ordinary share, one redeemable warrant and one right   ATMCU   N/A
Ordinary Shares, par value $0.0001 per share   ATMC   N/A
Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share   ATMCW   N/A
Rights, each right entitling the holder thereof to one-tenth of one ordinary share   ATMCR   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of November 12, 2026, there were 2,545,432 ordinary shares, par value $0.0001 issued and outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

      Page
       
Part I. Financial Information   F-1
       
Item 1. Condensed Financial Statements   F-1
       
  Condensed Balance Sheets as of March 31, 2026 (Unaudited) and December 31, 2025   F-1
       
  Unaudited Condensed Statements of Operations for the three months ended March 31, 2026 and 2025   F-2
       
  Unaudited Condensed Statements of Changes in Shareholders’ Equity/(Deficit) for the three months ended March 31, 2026 and 2025   F-3
       
  Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2026 and 2025   F-4
       
  Notes to Unaudited Condensed Financial Statements   F-5
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   1
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk   4
       
Item 4. Controls and Procedures   4
       
Part II. Other Information   5
       
Item 1. Legal Proceedings   5
       
Item 1A. Risk Factors   5
       
Item 2. Unregistered Sales of Equity Securities   5
       
Item 5. Other Information   5
       
Item 6. Exhibits   6
       
Signatures   7

 

i

 

 

PART I - FINANCIAL INFORMATION

 

ALPHATIME ACQUISITION CORP

CONDENSED BALANCE SHEETS

 

   March 31, 2026   December 31, 2025 
Assets:          
Current assets:          
Cash  $1,233   $1,233 
Prepaid expenses   74,642    1,773 
Total current assets   75,875    3,006 
           
Investment held in Trust Account   4,841,963    4,800,584 
Total assets  $4,917,838    4,803,590 
Liabilities and Shareholders’ Deficit:          
Current liabilities:          
Accounts payable and accrued expenses  $1,638,831   $1,462,474 
Promissory notes – related party   1,262,500    1,262,500 
Due to HCYC   766,690    752,363 
Due to related parties   899,028    814,700 
Total current liabilities   4,567,049    4,292,037 
Deferred underwriting commission   2,415,000    2,415,000 
Total liabilities   6,982,049    6,707,037 
Commitments and Contingencies   -    - 
Temporary Equity:          
Ordinary shares subject to possible redemption, 417,367 and 417,436 shares at redemption value of approximately $11.60 and $11.50 per share as of March 31, 2026 and December 31, 2025, respectively   4,841,963    4,800,584 
           
Shareholders’ Deficit:          
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding   -    - 
Ordinary Shares, $0.0001 par value; 200,000,000 shares authorized; 2,134,200 shares issued and outstanding at March 31, 2026 and December 31, 2025   214    214 
Additional paid-in capital   -    - 
Accumulated deficit   (6,906,388)   (6,704,245)
Total Shareholders’ Deficit   (6,906,174)   (6,704,031)
Total Liabilities, Temporary Equity and Shareholders’ Deficit  $4,917,838   $4,803,590 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

F-1

 

 

ALPHATIME ACQUISITION CORP

CONDENSED STATEMENTS OF OPERATIONS

For the three months ended March 31, 2026 and 2025 (Unaudited)

 

   2026   2025 
   Three months ended March 31, 
   2026   2025 
         
Formation and operating costs  $202,143   $183,402 
           
Total Expenses  $(202,143)  $(183,402)
Other income          
Income earned on Trust Account   42,268    301,371 
Net income (loss)  $(159,875)  $117,969 
           
Weighted average shares outstanding of redeemable ordinary shares   417,384    1,335,250 
Basic and diluted net income per share, redeemable ordinary shares  $0.02   $0.20 
Weighted average shares outstanding of non-redeemable ordinary shares   2,134,200    2,134,200 
Basic and diluted net loss per share, non-redeemable ordinary shares   (0.08)   (0.07)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

F-2

 

 

ALPHATIME ACQUISITION CORP

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY/(DEFICIT)

(UNAUDITED)

 

For the three months ended March 31, 2026

 

   Shares   Amount   Additional
paid-in
capital
   Accumulated
deficit
   Total
shareholders’
deficit
 
Balance as of December 31, 2025   2,134,200   $214   $          -   $(6,704,245)  $    (6,704,031)
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) and deposit   -    -    -    (42,268)   (42,268)
Net loss   -    -    -    (159,875)   (159,875)
Balance as of March 31, 2026   2,134,200   $214   $-   $(6,906,388)  $(6,906,174)

 

For the three months ended March 31, 2025

 

   Shares   Amount   Additional
paid-in
capital
   Accumulated
deficit
   Total
shareholders’
deficit
 
Balance as of December 31, 2024   2,134,200   $214   $          -   $(5,729,976)  $    (5,729,762)
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) and deposit   -    -    -    (356,350)   (356,350)
Net income   -    -    -    117,969    117,969 
Balance as of March 31, 2025   2,134,200   $214   $-   $(5,968,357)  $(5,968,143)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

F-3

 

 

ALPHATIME ACQUISITION CORP

CONDENSED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2026 and 2025 (Unaudited)

 

   2026   2025 
   Three months ended March 31, 
   2026   2025 
Cash Flows from Operating Activities:          
Net income (loss)  $(159,875)  $117,969 
Adjustments to reconcile net income to net cash used in operating activities:          
Income earned on Trust Account   (42,268)   (301,371)
Changes in current assets and liabilities:          
Prepaid expenses   (72,869)   (60,048)
Accounts payable and accrued expenses   176,357    391 
Due to HCYC   14,327    141,811 
Due to related parties   84,328    156,179 
Net cash provided by operating activities  $-   $54,931 
           
Cash Flows from Investing Activities:          
Principal deposited in Trust Account  $-   $(54,979)
Cash withdrawn from Trust Account in connection with redemption   889    - 
Net cash provided by (used in) investing activities  $889   $(54,979)
           
Cash Flows from Financing Activities:          
Redemption of ordinary shares   (889)   - 
Net cash (used in) provided by financing activities  $(889)  $- 
           
Net change in cash   -    (48)
Cash—beginning of the period   1,233    1,425 
Cash—end of the period  $1,233   $1,377 
           
Supplemental disclosure of noncash financing activities:          
Remeasurement adjustment on ordinary shares subject to possible redemption  $42,268   $356,350 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

F-4

 

 

ALPHATIME ACQUISITION CORP

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 1 — Description of Organization, Business Operations and Liquidity

 

AlphaTime Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on September 15, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of March 31, 2026, the Company had not commenced any operations. All activity for the period from September 15, 2021 (inception) through March 31, 2026 relates to the Company’s organizational activities, those necessary to prepare for and complete the initial public offering (“IPO”), identifying a target company for a Business Combination, and activities in connection with the proposed Business Combination described below. The Company will not generate any operating revenues until the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of income earned on the proceeds held in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.

 

The Company’s sponsor is Alphamade Holding LP, a Delaware limited partnership (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on December 30, 2022. On January 4, 2023, the Company consummated the IPO of 6,000,000 units (the “Units”). Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), one redeemable warrant (the “Warrants”) and one right (the “Rights”), with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share upon the completion of an initial Business Combination, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $60,000,000. On January 6, 2023, Chardan Capital Markets, LLC exercised its over-allotment option in full, which closed on January 9, 2023, generating additional gross proceeds to the Company of $9,000,000 from the sale of an additional 900,000 Units at $10.00 per Unit.

 

Simultaneously with the closing of the IPO, the Company completed the sale of 370,500 private units to the Sponsor (the “Private Units”) at a purchase price of $10.00 per Private Unit, generating gross proceeds to the Company of $3,705,000. Simultaneously with the closing of the over-allotment, the Company completed the private sale of an additional 38,700 Private Units, generating additional gross proceeds of $387,000. Transaction costs amounted to $4,892,699, consisting of $1,612,500 of underwriting discount, $2,415,000 of deferred underwriting commission and $865,199 of other offering costs.

 

Following the closing of the IPO and the sale of over-allotment Units, an aggregate of $70,242,000 of the proceeds from the IPO and the sale of the Private Units was placed in a U.S.-based trust account (the “Trust Account”) maintained by Equiniti Trust Company, LLC, acting as trustee, to be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 180 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act. Except with respect to income earned on the funds held in the Trust Account that may be released to the Company to pay income tax obligations, the proceeds held in the Trust Account will not be released until the earliest of the completion of a Business Combination, the redemption of the Public Shares in connection with a shareholder vote to amend the Company’s governing documents, or the Company’s liquidation.

 

The Company initially had 9 months (or up to 18 months, if we extend the time to complete a business combination) from January 4, 2023, the closing of the Initial Public Offering to consummate a Business Combination (the “Combination Period”).

 

F-5

 

 

Proposed Business Combination

 

On January 5, 2024, the Company entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”) by and among the Company, HCYC Holding Company (“PubCo”), ATMC Merger Sub 1 Limited, ATMC Merger Sub 2 Limited, HCYC Merger Sub Limited, and HCYC Group Company Limited, a Cayman Islands exempted company (“HCYC”), providing for a business combination by means of a series of mergers among the Company, the merger subsidiaries and HCYC. On November 12, 2025, the registration statement on Form F-4 relating to the proposed business combination with HCYC was declared effective by the SEC.

 

On December 5, 2025, the Company held an extraordinary general meeting of shareholders (the “BC Meeting”) at which the Company’s shareholders approved the Merger Agreement and the transactions contemplated thereunder. In connection with the BC Meeting, shareholders holding an aggregate of 382,091 Ordinary Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. The Business Combination has not been consummated and such redemptions have not become effective. On September 14, 2025, the Company entered into Securities Purchase Agreements with certain accredited investors for a private placement of an aggregate of $11.5 million of its Ordinary Shares (1,150,000 shares at $10.00 per share) and accompanying warrants to purchase up to 2,300,000 Ordinary Shares at an exercise price of $10.00 per share (the “PIPE Financing”), expected to close substantially concurrently with the closing of the Business Combination.

 

Extensions and Redemptions

 

The Company has extended the date by which it must complete an initial Business Combination on a number of occasions through amendments to its governing documents and the Investment Management Trust Agreement, dated as of December 30, 2022, with Equiniti Trust Company, LLC (as amended, the “Trust Agreement”), funded by deposits into the Trust Account in exchange for non-interest bearing, unsecured promissory notes payable upon the consummation of a Business Combination.

 

On September 27, 2023, the Company extended the time to complete its initial business combination from October 4, 2023 to January 4, 2024 by depositing an aggregate of $690,000 into the Trust Account. In connection with this extension, on September 26, 2023, the Company also entered into a non-interest bearing promissory note with the Sponsor for $690,000, is payable on the earlier of January 4, 2025 or promptly after the completion of an initial business combination. On April 14, 2025, the Company entered into an amended and restated promissory note which extends the maturity date to be due promptly after the completion of the initial business combination.

 

At an extraordinary general meeting of shareholders held on December 28, 2023 (the “Meeting”), the Company adopted the Company’s Third Amended and Restated Memorandum and Articles of Association (the “Third Amended and Restated Memorandum and Articles of Association”) reflecting the extension of the date by which the Company must consummate a business combination from January 4, 2024 (the “Termination Date”) up to ten (10) times, the first extension comprised of three months, and the subsequent nine (9) extensions comprised of one month each (each an “Extension”) up to January 4, 2025 (i.e., for a period of time ending up to 24 months after the consummation of its Initial Public Offering for a total of twelve (12) months after the Termination Date (assuming a business combination has not occurred). The Company also entered into an amendment (the “Trust Agreement Amendment”) to the Investment Management Trust Agreement, dated as of December 30, 2022, with Equiniti Trust Company, LLC (as amended, the “Trust Agreement”). Pursuant to the Trust Agreement Amendment, the Company has extended the date by which it has to complete a business combination from the Termination Date up to ten (10) times, with the first extension comprised of three months, and the subsequent nine (9) extensions comprised of one month each from the Termination Date, or extended date, as applicable, to January 4, 2025 by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the Trust Account $55,000 for each monthly extension (the “Extension Payment”) until January 4, 2025 (assuming a business combination has not occurred) in exchange for a non-interest bearing, unsecured promissory note payable upon the consummation of a business combination.

 

In connection with the shareholders’ vote at the meeting on December 28, 2023, 2,160,774 ordinary shares of the Company exercised their right to redeem such shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result, approximately $23,302,146 (approximately $10.78 per share) has been removed from the Trust Account to pay such holders and approximately $51,252,520 remained in the Trust Account. Following the Redemption, the Company had 6,873,426 Ordinary Shares outstanding.

 

F-6

 

 

At an extraordinary general meeting of shareholders held on December 20, 2024 (the “Second Meeting”), the Company adopted an amendment to the Third Amended and Restated Memorandum and Articles of Association (the “Amendment”) reflecting the extension of the date by which the Company must consummate a business combination from January 4, 2025 (the “Termination Date”) up to nine (9) times, each comprised of one month each (each an “Extension”) up to October 4, 2025 (i.e., for a period of time ending up to 33 months after the consummation of its Initial Public Offering for a total of nine (9) months after the Termination Date (assuming a business combination has not occurred). The Company also entered into an amendment (the “Second Trust Agreement Amendment”) to the Trust Agreement. Pursuant to the Second Trust Agreement Amendment, the Company has extended the date by which it has to complete a business combination from the Termination Date up to nine (9) times, each comprised of one month each from the Termination Date, or extended date, as applicable, to October 4, 2025 by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the Trust Account an Extension Payment of $55,000 per one-month extension until October 4, 2025 (assuming a business combination has not occurred) in exchange for a non-interest bearing, unsecured promissory note payable upon the consummation of a business combination.

 

In connection with the shareholders’ vote at the Second Meeting, holders of 3,403,976 Ordinary Shares of the Company exercised their right to redeem such shares (the “Second Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result, approximately $38,852,320.60 (approximately $11.41 per share) was removed from the Trust Account to pay such holders and approximately $15,240,284 remained in the Trust Account. Following the aforementioned redemptions, the Company had 3,469,450 Ordinary Shares outstanding.

 

On October 1, 2025, the Company held an extraordinary general meeting (the “Third Meeting”), solely with respect to voting on (i) the proposal to extend the date by which the Company must complete its initial business combination from October 4, 2025 to January 4, 2026, with all three (3) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend the Termination Date up to three (3) times, with each extension comprised of one month each from the Termination Date, or extended date, as applicable, to January 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the trust account $55,000 for each monthly extension until January 4, 2026.

 

In connection with the shareholders’ vote at the Third Meeting, holders of 917,814 ordinary shares of the Company exercised their right to redeem such shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result, $11,362,537(approximately $12.38 per share) was removed from the Trust Account to pay such holders and approximately $4,763,807 remained in the Trust Account. Following the aforementioned redemptions, the Company had 2,551,636 Ordinary Shares outstanding.

 

On December 16, 2025, the Company held an extraordinary general meeting (the “Fourth Meeting”), solely with respect to voting on (i) the proposal to extend the date by which the Company must complete its initial business combination from January 4, 2026 to April 4, 2026, with all three (3) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend the Termination Date up to three (3) times, with each extension comprised of one month each from the Termination Date, or extended date, as applicable, to April 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the trust account $1 for each monthly extension until April 4, 2026.

 

In connection with the shareholders’ vote at the Fourth Meeting, holders of 69 ordinary shares of the Company exercised their right to redeem such shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result, $889.39 (approximately $12.89 per share) was removed from the Trust Account to pay such holders and approximately $4,814,570.90 remained in the Trust Account. Following the aforementioned redemptions, the Company had 2,551,567 Ordinary Shares outstanding.

 

F-7

 

 

On March 27, 2026, the Company held an extraordinary general meeting (the “Fifth Meeting”), solely with respect to voting on (i) the proposal to extend the date by which the Company must complete its initial business combination from April 4, 2026 to December 4, 2026, with all eight (8) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend the Termination Date up to eight (8) times, with each extension comprised of one month each from the Termination Date, or extended date, as applicable, to December 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the trust account $15,000 for each monthly extension until December 4, 2026. Shareholder approval of the Fifth Meeting proposals authorized, but did not itself effect, such extensions; each monthly extension is effective only upon satisfaction of the applicable notice and deposit conditions.

 

In connection with the shareholders’ vote at the Fifth Meeting, holders of 6,135 ordinary shares of the Company exercised their right to redeem such shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. Such shares remained outstanding and were included in ordinary shares subject to possible redemption as of March 31, 2026. In April 2026, subsequent to the end of the quarter, $79,701.15 (approximately $12.99 per share) was removed from the Trust Account to pay such holders and approximately $4,776,622 remained in the Trust Account. Following such payment, the Company had 2,545,432 Ordinary Shares outstanding, of which 411,232 were subject to possible redemption. As of March 31, 2026, the Company had 2,551,567 Ordinary Shares outstanding, of which 417,367 were subject to possible redemption.

 

On January 4, 2024, the Company deposited $165,000 into the Trust Account to extend the deadline to complete the business combination from January 4, 2024 to April 4, 2024. In connection with this extension, on December 28, 2023, the Company entered into a non-interest bearing promissory note with the Sponsor for $660,000, that is payable promptly after the completion of an initial business combination. Further, the Company has deposited a total of $489,979 into the Trust Account in connection with extensions of the deadline to complete the business combination from April 4, 2024 to January 4, 2025. The total deposits made to date were $5,021 less than the amount required to fully fund the extensions through February 4, 2025, and, as a result, a portion of the extensions remained unfunded as of March 31, 2026. Thereafter, the Company delivered additional extension letters requesting to extend the timeline of the business combination on a monthly basis through December 4, 2026. As of March 31, 2026, the extension payments in aggregate totaling $565,144 had not yet been deposited into the Trust Account and, accordingly, did not accrue interest income during the period. These extension payments were also not included in the ordinary shares subject to possible redemption as of March 31, 2026. Because the required extension payments were not deposited in full, there is uncertainty as to whether some or all of such extensions were effected in accordance with the Company’s amended and restated memorandum and articles of association and the Trust Agreement, and as to the date by which the Company was or is required to complete a Business Combination.

 

Nasdaq Delisting

 

On January 8, 2026, The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company that on January 13, 2026, it would announce that it will delist the Company’s ordinary shares, warrants, rights and units as a result of the Company exceeding the maximum three-year period permitted for a special purpose acquisition company to complete an initial business combination following its initial public offering. Trading in the Company’s securities was suspended on January 7, 2026, and the Company’s securities have not traded on Nasdaq since December 9, 2025. On January 15, 2026, Nasdaq filed a Form 25 with the SEC to remove the Company’s ordinary shares, rights, units and warrants from listing on Nasdaq and to withdraw the registration of such securities under Section 12(b) of the Exchange Act. The delisting became effective ten days after the Form 25 was filed, and the withdrawal of registration under Section 12(b) became effective 90 days after the Form 25 was filed. As of the date of this report, the Company’s securities are not listed on any national securities exchange.

 

Liquidity and Going Concern

 

As of March 31, 2026, the Company had $1,233 in cash held outside of the Trust Account and a working capital deficit of $4,491,174. In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan funds to the Company as may be required. As of March 31, 2026, there was $1,262,500 outstanding under promissory notes issued to the Sponsor and $766,690 outstanding under amounts borrowed from HCYC.

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company’s working capital deficit and the mandatory liquidation and subsequent dissolution that would be required should the Company be unable to complete a Business Combination within the applicable period raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, management has adopted plans intended to address the substantial doubt about the Company’s ability to continue as a going concern. Management intends to continue to pursue the consummation of the Business Combination with HCYC. Prior to the consummation of a Business Combination, the Company intends to cover any working capital shortfalls through extension loans and other financing arrangements. In addition, the Company is seeking alternative ways to complete the Business Combination, including applying to have the Company’s securities quoted on the OTC market, in order to maintain the Company’s public trading status and facilitate the completion of the Business Combination. Notwithstanding these plans, management cannot conclude that it is probable that its plans will be effectively implemented within one year after the date that the unaudited condensed financial statements are available to be issued, or that, if implemented, the plans will mitigate the conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Note 2 — Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026 or any future period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

 

F-8

 

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Accordingly, actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $1,233 as of each of March 31, 2026 and December 31, 2025.

 

Investment Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of investments in U.S. government securities, generally having a readily determinable fair value. Gains and losses resulting from the change in fair value of these securities and income earned on the investments held in the Trust Account are included in income earned on the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2026 and December 31, 2025, 417,367 and 417,436 ordinary shares subject to possible redemption are presented at a redemption value of approximately $11.60 and $11.50 per share, respectively, as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.

 

F-9

 

 

At March 31, 2026, the ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

 

Ordinary shares subject to possible redemption at December 31, 2025  $4,800,584 
Redemption of ordinary shares   (889)
Subsequent measurement of ordinary shares subject to possible redemption   42,268 
Ordinary shares subject to possible redemption at March 31, 2026  $4,841,963 

 

Net Income (Loss) Per Share

 

The Company complies with the accounting and disclosure requirements of FASB ASC 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period, allocated between the redeemable ordinary shares and the non-redeemable ordinary shares using the two-class method. Remeasurement of the carrying value of ordinary shares subject to possible redemption to redemption value is treated as a deemed dividend to the redeemable shareholders. As of March 31, 2026, the Company did not have any dilutive securities that could potentially be exercised or converted into ordinary shares. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the periods presented.

 

The following table presents the calculation of basic and diluted net income (loss) per share:

 

  

For the three months

ended

March 31, 2026

  

For the three months

ended

March 31, 2025

 
         
Net income (loss)  $(159,875)  $117,969 
Income earned on Trust Account   (42,268)   (301,371)
Accretion of carrying value to redemption value   -    (54,979)
Net loss including accretion of equity into redemption value  $(202,143)  $(238,381)

 

 

   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
  

Three months ended

March 31, 2026

  

Three months ended

March 31, 2025

 
   Redeemable  

Non-

Redeemable

   Redeemable  

Non-

Redeemable

 
Particulars  Shares   Shares   Shares   Shares 
Basic and diluted net income/(loss) per share:                    
Numerators:                    
Allocation of net loss including accretion of temporary equity  $(33,066)  $(169,077)  $(91,743)  $(146,638)
Income earned on Trust Account   42,268    —    301,371    — 
Accretion of temporary equity to redemption value   —    —    54,979    — 
Allocation of net income/(loss)  $9,202   $(169,077)  $264,607   $(146,638)
                     
Denominators:                    
Weighted-average shares outstanding   417,384    2,134,200    1,335,250    2,134,200 
Basic and diluted net income/(loss) per share  $0.02   $(0.08)  $0.20   $(0.07)

 

F-10

 

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. As of March 31, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

 

Note 3 — Initial Public Offering

 

Pursuant to the IPO, the Company sold 6,900,000 Units (including 900,000 Units sold pursuant to the underwriters’ full exercise of the over-allotment option) at a purchase price of $10.00 per Unit. Each Unit consists of one Ordinary Share, one redeemable Warrant and one Right. Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment, and is exercisable commencing on the later of 30 days after the completion of the initial Business Combination and 12 months from the closing of the IPO, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. Each Right entitles the holder thereof to receive one-tenth (1/10) of one Ordinary Share upon the consummation of the initial Business Combination.

 

Note 4 — Private Placement

 

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 370,500 Private Units at a price of $10.00 per Private Unit, generating gross proceeds of $3,705,000. Simultaneously with the closing of the over-allotment, the Company sold an additional 38,700 Private Units to the Sponsor, generating additional gross proceeds of $387,000. Each Private Unit consists of one Ordinary Share, one Warrant and one Right, and is identical to the Units sold in the IPO except as described in the Company’s registration statement. The proceeds from the sale of the Private Units were added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the applicable period, the proceeds from the sale of the Private Units held in the Trust Account will be used to fund the redemption of the Public Shares, and the Private Units and their underlying securities will expire worthless.

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On September 28, 2021, the Sponsor purchased 1,437,500 of the Company’s Class B ordinary shares (the “Founder Shares”) for an aggregate purchase price of $25,000. On January 8, 2022, the Company effected a recapitalization pursuant to which the Founder Shares were reclassified into ordinary shares and the Sponsor was issued additional shares, resulting in an aggregate of 1,725,000 Founder Shares outstanding, of which up to 225,000 were subject to forfeiture to the extent the over-allotment option was not exercised in full. As a result of the underwriters’ exercise of the over-allotment option in full, no Founder Shares were forfeited.

 

Promissory Notes — Related Party

 

The Company has issued a series of unsecured promissory notes to the Sponsor to finance working capital and costs associated with extending the period available to complete a Business Combination. The notes are non-interest bearing and are payable upon the consummation of a Business Combination. As of March 31, 2026 and December 31, 2025, the aggregate amount outstanding under the promissory notes issued to the Sponsor was $1,262,500.

 

Due to Related Parties

 

From time to time, the Sponsor and the Company’s officers and directors advance funds to the Company, or pay expenses on behalf of the Company, for working capital purposes. As of March 31, 2026 and December 31, 2025, the amount due to related parties was $899,028 and $814,700, respectively.

 

Administrative Support Agreement

 

Commencing on the effective date of the IPO, the Company agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, administrative and shared personnel support services. For each of the three months ended March 31, 2026 and 2025, the Company incurred $30,000 of such fees.

 

F-11

 

 

Note 6 — Commitments and Contingencies

 

Registration Rights

 

The holders of the Founder Shares, Private Units (and underlying securities) and any units that may be issued upon conversion of working capital loans are entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to a specified number of demands that the Company register such securities and to certain “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The underwriters were paid an underwriting discount of $1,612,500 in connection with the IPO. In addition, the underwriters are entitled to a deferred underwriting commission of $2,415,000, equal to $0.35 per Unit sold in the IPO, payable solely in the event the Company completes a Business Combination, subject to the terms of the underwriting agreement. The Company also sold to the underwriters, for $100, a unit purchase option to purchase up to 58,000 Units exercisable at $11.50 per Unit.

 

Due to HCYC

 

HCYC, the Company’s proposed business combination target, has from time to time paid certain expenses on behalf of the Company. As of March 31, 2026 and December 31, 2025, the amount due to HCYC was $766,690 and $752,363, respectively.

 

Note 7 — Shareholders’ Deficit

 

Preferred Shares — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share. As of March 31, 2026 and December 31, 2025, there were no preferred shares issued or outstanding.

 

Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $0.0001 per share. As of March 31, 2026 and December 31, 2025, there were 2,134,200 ordinary shares issued and outstanding, excluding 417,367 and 417,436 ordinary shares, respectively, subject to possible redemption that are classified as temporary equity.

 

Warrants — Each Warrant entitles the holder to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment. The Warrants are exercisable commencing on the later of 30 days after the completion of the initial Business Combination and 12 months from the closing of the IPO, and expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. The Company accounts for the Warrants and the Rights as equity-classified instruments based on an assessment of their specific terms and the applicable authoritative guidance in ASC 480 and ASC 815.

 

Note 8 — Fair Value Measurements

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. The Company’s investments held in the Trust Account are classified within Level 1 of the fair value hierarchy because they are valued using quoted prices in active markets for identical assets. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation inputs utilized:

 

      March 31, 2026   December 31, 2025 
Investments held in Trust Account  Level 1  $4,841,963   $4,800,584 

 

Note 9 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment to or disclosure in the unaudited condensed financial statements, other than as described below.

 

At the Fifth Meeting held on March 27, 2026, the Company’s shareholders approved the proposals to extend the date by which the Company must complete its initial business combination from April 4, 2026 up to eight (8) times, with each extension comprised of one month, to December 4, 2026, and to amend the Trust Agreement accordingly, with the Company to deposit $15,000 into the Trust Account for each monthly extension. In connection with the vote at the Fifth Meeting, holders of 6,135 Ordinary Shares exercised their right to redeem such shares for a pro rata portion of the funds held in the Trust Account.

 

In April 2026, the Company paid $79,701.15 (approximately $12.99 per share) from the Trust Account to the holders of the 6,135 Ordinary Shares that exercised their redemption rights in connection with the Fifth Meeting. Following such redemption, the Company had 2,545,432 Ordinary Shares outstanding, of which 411,232 Ordinary Shares were subject to possible redemption, and approximately $4,776,622 remained in the Trust Account.

 

Subsequent to March 31, 2026, the target company, HCYC, paid certain additional operating costs on behalf of the Company amounting to $125,611.

 

F-12

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and our audited financial statements and the related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements. Because we are a blank check company, the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, may not be available to us. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results expressed or implied by these forward-looking statements. Except as required by applicable law, we do not undertake any obligation to update or revise any forward-looking statements.

 

Overview

 

We are a blank check company incorporated in the Cayman Islands on September 15, 2021 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

 

Our registration statement for our initial public offering (the “Initial Public Offering”) was declared effective on December 30, 2022. On January 4, 2023, we consummated the Initial Public Offering of 6,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $60,000,000. On January 9, 2023, the underwriters exercised their over-allotment option in full, resulting in the sale of an additional 900,000 Units at $10.00 per Unit, generating additional gross proceeds of $9,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 370,500 private placement units (the “Private Placement Units”) at $10.00 per unit, generating gross proceeds of $3,705,000, and, on January 9, 2023, simultaneously with the sale of the over-allotment Units, we consummated the sale of an additional 38,700 Private Placement Units, generating additional gross proceeds of $387,000. A total of $70,242,000 (or $10.18 per Unit sold in the Initial Public Offering) was placed in the trust account (the “Trust Account”).

 

On March 27, 2026, we held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) to approve, among other things, the Extension Amendment Proposal and the Trust Agreement Amendment Proposal. In connection with the vote to approve the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, the holders of 6,135 ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $12.99 per share. The aggregate redemption amount of approximately $79,701.15 was paid in April 2026, subsequent to the end of the quarter. Separately, in January 2026, 69 ordinary shares tendered in connection with the Fourth Meeting were redeemed for $889.39 (approximately $12.89 per share).

 

As of March 31, 2026, we had not commenced any operations. All activity through March 31, 2026 relates to our formation and the Initial Public Offering and, since the closing of the Initial Public Offering, the search for a prospective initial Business Combination and activities in connection with the proposed Business Combination with HCYC. On January 5, 2024, we entered into the Merger Agreement with HCYC, and on December 5, 2025, our shareholders approved the Merger Agreement at the BC Meeting. The Business Combination has not been consummated as of the date of this report. The PIPE Financing of $11.5 million is expected to close substantially concurrently with, and is conditioned on, the closing of the Business Combination. Our securities were delisted from Nasdaq following the Form 25 filed on January 15, 2026. We do not expect to generate any operating revenues until after the completion of our initial Business Combination, at the earliest. We generate non-operating income in the form of income earned on investments held in the Trust Account.

 

1

 

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through March 31, 2026 were organizational activities, those necessary to prepare for the Initial Public Offering and, since the Initial Public Offering, the identification and evaluation of a prospective target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

 

For the three months ended March 31, 2026, we had a net loss of $159,875, which consisted of formation and operating costs of $202,143, partially offset by income earned on the Trust Account of $42,268.

 

For the three months ended March 31, 2025, we had net income of $117,969, which consisted of income earned on the Trust Account of $301,371, partially offset by formation and operating costs of $183,402.

 

Income earned on the Trust Account decreased from $301,371 for the three months ended March 31, 2025 to $42,268 for the three months ended March 31, 2026, primarily due to the lower balance held in the Trust Account following redemptions in connection with prior extension meetings, and changes in prevailing interest rates. Formation and operating costs increased from $183,402 to $202,143.

 

Liquidity and Capital Resources

 

As of March 31, 2026, we had cash of $1,233 held outside of the Trust Account and a working capital deficit of $4,491,174. As of March 31, 2026, we had investments held in the Trust Account of $4,841,963. Income earned on the Trust Account may be used by us to pay taxes. Through March 31, 2026, we have not withdrawn any income earned on the Trust Account to pay our tax obligations.

 

Funds held in the Trust Account are subject to the redemption rights of our public shareholders and are not available to fund our working capital. Of the Trust Account balance at March 31, 2026, $79,701.15 was paid in April 2026 to holders who redeemed in connection with the Fifth Meeting, and holders of 382,091 ordinary shares have elected to redeem in connection with the Business Combination, which redemptions will become effective only upon closing. In addition, $565,144 of extension payments had not been deposited into the Trust Account as of March 31, 2026. As a result, the funds that may be available from the Trust Account upon closing of the Business Combination are expected to be substantially less than the Trust Account balance. Subject to the foregoing, we intend to use the funds held in the Trust Account remaining after redemptions, including any amounts representing income earned on the Trust Account (less amounts released to pay taxes), to complete our initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. We have limited liquidity. As of March 31, 2026, we had only $1,233 of unrestricted cash and a working capital deficit of $4,491,174, and we have relied on advances from our Sponsor, our officers and directors and HCYC to fund operating expenses. None of these parties is obligated to provide further funding. Completion of the Business Combination is also dependent on the PIPE Financing, which is conditioned on the closing.

 

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. As of March 31, 2026, there was $1,262,500 outstanding under promissory notes payable to a related party and $766,690 outstanding under amounts borrowed from HCYC.

 

Going Concern

 

In connection with our assessment of going concern considerations in accordance with Accounting Standards Update 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, together with the Company’s working capital deficit, raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, management has adopted plans intended to address the substantial doubt about the Company’s ability to continue as a going concern. Management intends to continue to pursue the consummation of the Business Combination with HCYC. Prior to the consummation of a Business Combination, the Company intends to cover any working capital shortfalls through extension loans and other financing arrangements. In addition, the Company is seeking alternative ways to complete the Business Combination, including applying to have the Company’s securities quoted on the OTC market, in order to maintain the Company’s public trading status and facilitate the completion of the Business Combination. Notwithstanding these plans, management cannot conclude that it is probable that its plans will be effectively implemented within one year after the date that the unaudited condensed financial statements are available to be issued, or that, if implemented, the plans will mitigate the conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the relevant date by which it must complete a Business Combination.

 

In addition, because the required extension payments were not deposited in full, there is uncertainty as to whether the extensions were validly effected and as to the date by which we are required to complete a Business Combination, which could require us to redeem our public shares and wind up earlier than anticipated.

 

Off-Balance Sheet Arrangements

 

We did not have any off-balance sheet arrangements as of March 31, 2026.

 

2

 

 

Contractual Obligations

 

As of March 31, 2026, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the deferred underwriting commission of $2,415,000 payable to the underwriters of our Initial Public Offering upon the completion of our initial Business Combination, and an agreement to pay an affiliate of our Sponsor a monthly fee for office space, secretarial and administrative support services.

 

Critical Accounting Estimates

 

The preparation of these unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting estimates:

 

Ordinary Shares Subject to Possible Redemption. We account for our ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. We recognize changes in redemption value immediately as they occur and adjust the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.

 

Net Income (Loss) per Ordinary Share. We comply with the accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the periods. We apply the two-class method in calculating earnings per share, allocating net income (loss) between the redeemable ordinary shares and the non-redeemable ordinary shares.

 

Recent Accounting Pronouncements

 

Our management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our unaudited condensed financial statements.

 

Emerging Growth Company Status

 

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and we have elected to take advantage of the benefits of the extended transition period for complying with new or revised accounting standards. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. We are also a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

 

3

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated, as of March 31, 2026, the effectiveness of our disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) and Rule 15d-15(e). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 31, 2026, due to the material weakness in our internal control over financial reporting related to insufficient review of related party transactions, as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2025. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited condensed financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

 

Management intends to continue to implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we intend to expand and improve our review process for related party transactions and ensure that communication with related parties is sufficient to ensure completeness of related party transactions. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

 

We believe, however, that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, within a company have been detected.

 

Changes in Internal Control over Financial Reporting

 

Other than the remediation efforts implemented during the quarter described above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

4

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

To the knowledge of our management, there is no material litigation, arbitration, bankruptcy, receivership, governmental proceeding or other proceeding currently pending against us or any members of our management team in their capacity as such.

 

Item 1A. Risk Factors

 

As of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on November 10, 2026.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Use of Proceeds

 

On January 4, 2023, the Company consummated the initial public offering of 6,000,000 Units (the “Units” and, with respect to the Ordinary shares included in the Units sold, the “Public Shares”), and an additional 900,000 Units issued on January 9, 2023 pursuant to the underwriters’ exercise in full of their over-allotment option, at $10.00 per Unit, generating aggregate gross proceeds of $69,000,000.

 

Simultaneously with the closing of the initial public offering, we consummated the sale of 370,500 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,705,000. On January 9, 2023, simultaneously with the sale of the over-allotment Units, the Company consummated the private sale of an additional 38,700 Private Placement Units, generating additional gross proceeds of $387,000.

 

Transaction costs related to the issuances described above amounted to $4,892,699 consisting of $1,612,500 of underwriting fees, $2,415,000 of deferred underwriting fees and $865,199 of other offering costs. Following the closing of the initial public offering and the sale of the Private Placement Units, an aggregate of $70,242,000 (or $10.18 per share sold in the initial public offering) was placed in the Trust Account.

 

Redemptions

 

On March 27, 2026, the Company held the Extraordinary General Meeting to vote on the Extension Amendment Proposal and the Trust Agreement Amendment Proposal. In connection with the vote to approve the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, the holders of 6,135 Ordinary Shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately $12.99 per share. The aggregate redemption amount of approximately $79,701.15 was paid in April 2026, subsequent to the end of the quarter. During the quarter ended March 31, 2026, the Company redeemed 69 Ordinary Shares in January 2026 for an aggregate of $889.39 (approximately $12.89 per share) in connection with the Fourth Meeting.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

5

 

 

Item 6. Exhibits

 

EXHIBIT INDEX

 

Exhibit Number   Description
     
3.1  

Form of Amendment to Third Amended and Restated Memorandum and Articles of Association, adopted on March 27, 2026. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 2, 2026).

     
10.1  

Amendment to the Investment Management Trust Agreement, dated March 27, 2026, by and between AlphaTime Acquisition Corp and Equiniti Trust Company, LLC. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 2, 2026).

     
31.1*   Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
     
31.2*   Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
     
32.1**   Certification of Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.
     
32.2**   Certification of Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema
     
101.CAL   Inline XBRL Taxonomy Calculation Linkbase
     
101.LAB   Inline XBRL Taxonomy Label Linkbase
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
101.DEF   Inline XBRL Definition Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

*Filed herewith.

 

**Furnished herewith.

 

6

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

 

November 12, 2026

 

  ALPHATIME ACQUISITION CORP
     
  By: /s/ Gan Kim Hai
    Gan Kim Hai
    Chief Executive Officer (Principal Executive Officer)

 

  By: /s/ Gan Kim Hai
   

Yingxuan Shan

Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

7

 

Keep reading